331 related articles for article (PubMed ID: 11238522)
1. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
2. A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies.
Chazenbalk GD; Wang Y; Guo J; Hutchison JS; Segal D; Jaume JC; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 1999 Feb; 84(2):702-10. PubMed ID: 10022441
[TBL] [Abstract][Full Text] [Related]
3. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
7. Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera.
Chazenbalk GD; Jaume JC; McLachlan SM; Rapoport B
J Biol Chem; 1997 Jul; 272(30):18959-65. PubMed ID: 9228077
[TBL] [Abstract][Full Text] [Related]
8. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
10. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
11. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
12. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies interacting with purified native thyrotropin receptor.
Atger M; Misrahi M; Young J; Jolivet A; Orgiazzi J; Schaison G; Milgrom E
Eur J Biochem; 1999 Nov; 265(3):1022-31. PubMed ID: 10518798
[TBL] [Abstract][Full Text] [Related]
14. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
Minich WB; Loos U
Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
[TBL] [Abstract][Full Text] [Related]
15. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
17. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
18. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
19. Dissecting linear and conformational epitopes on the native thyrotropin receptor.
Ando T; Latif R; Daniel S; Eguchi K; Davies TF
Endocrinology; 2004 Nov; 145(11):5185-93. PubMed ID: 15297445
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
